FDA Approves OTC Overdose Treatment
On March 29, the U.S. Food and Drug Administration (FDA) announced the approval of an over-the-counter (OTC) nasal spray for the treatment of opioid overdoses. Narcan, a 4 milligram (mg) naloxone hydrochloride nasal spray, is the first naloxone product approved for use without a prescription. The National Safety Council (NSC) said it “is thrilled workplaces […]